Loading...
Delivery of chemo-sensitizing siRNAs to HER2(+)-breast cancer cells using RNA aptamers
Human epidermal growth factor receptor 2 (HER2) expression in breast cancer is associated with an aggressive phenotype and poor prognosis, making it an appealing therapeutic target. Trastuzumab, an HER2 antibody-based inhibitor, is currently the leading targeted treatment for HER2(+)-breast cancers....
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3401474/ https://ncbi.nlm.nih.gov/pubmed/22467215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gks294 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|